Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

NCT06648772 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Roflumilast Cream 0.3%
DRUG: Vehicle cream

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.